Related Experiment Videos
Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin
F A Eskens1, E J Roelofs, A R Hermus
1Department of Medicine, University Hospital Nijmegen, The Netherlands.
Anticancer Research
|March 12, 1998
Abstract:
A patient with a pancreatic islet cell tumor concurrently producing vasoactive intestinal polypeptide (VIP) and calcitonin with related symptoms is presented. The patient was given palliative treatment consisting of octreotide, streptozotocin and 5-fluorouracil, and survival now exceeds 72 months. The concurrent production of VIP and calcitonin by a pancreatic islet cell tumor has not been described before.